ReviewBiosensors2025
Emerging Microfluidic Plasma Separation Technologies for Point-of-Care Diagnostics: Moving Beyond Conventional Centrifugation.
Review in Biosensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A rapid ADAMTS13 activity assay using a portable readout device.Blood vessels, thrombosis & hemostasis · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Plasma separation is an essential step in blood-based diagnostics. While traditional centrifugation is effective, it is costly and usually restricted to centralized laboratories because it requires relatively expensive equipment, a supply of consumables, and trained personnel. In an effort to alleviate these shortcomings, microfluidic and point-of-care devices offering rapid and low-cost plasma separation from small sample volumes, such as finger-stick samples, are quickly emerging as an alternative. Such microscale plasma separation systems enable reduced costs, rapid test results, self-testing, and broader accessibility, particularly in resource-limited or remote settings and facilitate the integration of separation, fluid handling, and downstream analysis into portable, automated lab-on-a-chip platforms. This review highlights advances in microfluidic systems and lab-on-a-chip devices for plasma separation categorized in design strategies, separation principles and characteristics, application purposes, and future directions for the decentralization of healthcare and personalized medicine.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.